Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of Effective Factors on Il-10 Signaling in B Cells in Patients With Selective Iga Deficiency Publisher Pubmed



Bagheri Y1, 2 ; Saeidi M1, 2 ; Yazdani R3, 4 ; Babaha F3 ; Falak R5, 6 ; Azizi G7 ; Taherian M5, 6 ; Salami F3 ; Yazdani Y1, 2 ; Sadani S8 ; Hosseini A8 ; Motallebnezhad M5, 6 ; Abolhassani H3, 9 ; Shekarabi M5, 6 Show All Authors
Authors
  1. Bagheri Y1, 2
  2. Saeidi M1, 2
  3. Yazdani R3, 4
  4. Babaha F3
  5. Falak R5, 6
  6. Azizi G7
  7. Taherian M5, 6
  8. Salami F3
  9. Yazdani Y1, 2
  10. Sadani S8
  11. Hosseini A8
  12. Motallebnezhad M5, 6
  13. Abolhassani H3, 9
  14. Shekarabi M5, 6
  15. Aghamohammadi A3
Show Affiliations
Authors Affiliations
  1. 1. Stem cell research center, Golestan university of medical sciences, Gorgan, Iran
  2. 2. Immunology department, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
  3. 3. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd., Tehran, 14194, Iran
  4. 4. Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States
  5. 5. Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Immunology, School of Medicine, Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran, 1449614535, Iran
  7. 7. Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
  8. 8. Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran
  9. 9. Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden

Source: European Cytokine Network Published:2021


Abstract

Background: Selective IgA deficiency is the most prevalent form of primary immunodeficiencies. The pathogenesis of the disease is still unknown. Several studies have suggested a defect in B cell responses to IL-10; however, the main reason for this defect has not been reported. Elucidating IL-10 signaling defects and their correlation with clinical manifestations could be helpful for better understanding and treatment of the disease. Methods: In this study, 15 SIgAD patients and 15 age- and sex-matched healthy controls were included. Surface expression of transforming growth factor β receptor II (TGF-β RII), IL-10R and IgA was assessed by flow cytometry in human purified B cells before and after stimulation by IL-10. Protein expression of STAT3, p-STAT3 and SOCS3 was measured by Western blotting analysis. TGF-β and IgA secretion was evaluated by ELISA. Finally, the measurement of B cell apoptosis was performed by flow cytometry. Results: The TGF-βRII expression level was decreased after stimulation with IL-10 in patients compared with controls. Notably, the TGF-β level were higher after stimulation with mCD40L and IL-10 in the control group as compared to stimulation with mCD40L alone. The IgA+ B cell percentage and IgA secretion levels were significantly increased in controls as compared with SIgAD patients. The relative concentration of the total STAT3 was decreased as compared with controls. Conclusion: The defect in IgA production in SIgAD patients could be due to inadequate B cell responses to IL-10 stimulation that probably originate from defective regulation of IL-10-mediated TGF-b ‘symbol’ production TGF-β response by IL-10. Furthermore, it is suggested that the absence of STAT3 protein baseline expression could impair cytokine-mediated signaling such as thatinduced by IL-!0 and IL-21. © 2021, JLE/Springer.
Other Related Docs
9. Monogenic Mutations Associated With Iga Deficiency, Expert Review of Clinical Immunology (2016)
11. The Clinical and Immunological Features of Patients With Primary Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2018)
13. Autoimmunity in Patients With Selective Iga Deficiency, Journal of Investigational Allergology and Clinical Immunology (2015)
14. Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (Cvid), Endocrine# Metabolic and Immune Disorders - Drug Targets (2017)
17. Application of Flow Cytometry in Predominantly Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)
19. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, Journal of Investigational Allergology and Clinical Immunology (2017)
21. Pulmonary Manifestations of Predominantly Antibody Deficiencies, Pulmonary Manifestations of Primary Immunodeficiency Diseases (2018)
22. A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency, Endocrine# Metabolic and Immune Disorders - Drug Targets (2017)